Evaxion A/S American Depositary Share (EVAX) Stock Price

EVAXStock

$3.35+4.62%52W

Market Cap$27.94M

P/E—

PEG Ratio—

Div yield—

Beta0.55

EVAX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-8.84%

Price vs S&P 500 (4W)18.38%

VGM Score66.82

Book Value / Share (Quarterly)$0.02

P/TBV (Annual)4.96x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.04

Price vs S&P 500 (YTD)-40.68%

Net Profit Margin (TTM)-50.24%

EPS (TTM)$-0.02

10-Day Avg Trading Volume1.08M

EPS Excl Extra (TTM)$-0.02

EPS (Annual)$-0.02

ROI (Annual)-31.40%

Cash / Share (Quarterly)$0.05

Revenue Growth QoQ (YoY)148.33%

ROA (Last FY)-27.13%

Revenue Growth TTM (YoY)128.64%

EBITD / Share (TTM)$-0.01

ROE (5Y Avg)-146.57%

Operating Margin (TTM)-69.77%

Cash Flow / Share (Annual)$-0.18

P/B Ratio1.57x

P/B Ratio (Quarterly)1.77x

Net Income / Employee (Annual)$-167,500

EV / Revenue (TTM)3.48x

Net Interest Coverage (TTM)-3.42x

ROA (TTM)-48.75%

EPS Incl Extra (Annual)$-0.02

Current Ratio (Annual)5.85x

Quick Ratio (Quarterly)5.66x

3-Month Avg Trading Volume0.14M

52-Week Price Return4.62%

Revenue / Employee (TTM)$163,700

Tangible BV / Share (Quarterly)$0.34

P/S Ratio (Annual)3.56x

Asset Turnover (Annual)0.27x

52-Week High$12.15

EPS Excl Extra (Annual)$-0.02

CapEx CAGR (5Y)-43.07%

26-Week Price Return2.41%

Quick Ratio (Annual)5.70x

13-Week Price Return-16.26%

Total Debt / Equity (Annual)0.44x

Current Ratio (Quarterly)5.85x

Enterprise Value$11.05M

Asset Turnover (TTM)0.19x

Revenue / Employee (Annual)$163,700

Pretax Margin (Annual)-114.44%

Cash / Share (Annual)$0.08

3-Month Return Std Dev60.16%

Net Income / Employee (TTM)$-212,200

ROE (Last FY)-45.23%

Net Interest Coverage (Annual)-1.78x

EPS Basic Excl Extra (Annual)$-0.02

Total Debt / Equity (Quarterly)0.44x

EPS Incl Extra (TTM)$-0.02

ROI (TTM)-71.05%

P/S Ratio (TTM)3.50x

Revenue / Share (Annual)$0.02

Tangible BV / Share (Annual)$0.34

Price vs S&P 500 (52W)-13.70%

Year-to-Date Return-28.72%

5-Day Price Return7.94%

EPS Normalized (Annual)$-0.02

ROA (5Y Avg)-89.94%

Net Profit Margin (Annual)-102.38%

Month-to-Date Return20.57%

EBITD / Share (Annual)$-0.02

Operating Margin (Annual)-88.55%

LT Debt / Equity (Annual)0.31x

ROI (5Y Avg)-111.21%

LT Debt / Equity (Quarterly)0.31x

EPS Basic Excl Extra (TTM)$-0.02

P/TBV (Quarterly)4.96x

P/B Ratio (Annual)1.77x

Pretax Margin (TTM)-59.78%

Book Value / Share (Annual)$0.34

Price vs S&P 500 (13W)-19.05%

Beta0.55x

Revenue / Share (TTM)$0.02

ROE (TTM)-111.18%

52-Week Low$2.52

vGradeB

gGradeA

mGradeC

vgmGradeB

EVAX Earnings Surprise History

Q2 25-1.00est. -0.58

Q3 250.01est. -0.01

Q4 25-0.01est. -0.01

Q1 26-0.01est. -0.01

Q2 26-0.01est. -0.01

EVAX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.10

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
EVAXEvaxion A/S American Depositary Share	B	A	C	$3.35
AMGNAmgen Inc	C	C	B	$442.24
GILDGilead Sciences Inc	C	B	B	$148.77
MRNAModerna, Inc. Common Stock	D	C	A	$158.83
ARGXargenx SE American Depositary Shares	D	A	B	$1019.49
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$211.38
BIIBBiogen Inc. Common Stock	C	D	B	$220.77
BNTXBioNTech SE American Depositary Share	C	C	B	$114.05
NBIXNeurocrine Biosciences Inc	C	B	C	$153.37
EXELExelixis Inc	C	B	B	$56.72
HALOHalozyme Therapeutics, Inc.	C	B	A	$109.32
TECHBio-Techne Corp.	D	C	B	$72.33
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$356.19
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$126.64
RGENRepligen Corp	D	C	A	$181.69
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.85
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$151.42
PCVXVaxcyte, Inc. Common Stock	—	—	B	$61.09
QGENQIAGEN N.V.	C	C	C	$43.65
IMVTImmunovant, Inc. Common Stock	—	—	B	$43.50
IBRXImmunityBio, Inc. Common Stock	F	A	C	$8.19
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$58.25
CGONCG Oncology, Inc. Common stock	F	A	A	$78.95
CRSPCRISPR Therapeutics AG	D	B	B	$60.90
RLAYRelay Therapeutics, Inc. Common Stock	F	D	A	$20.57
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$26.25
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.93
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.44
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$31.03
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.45
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.83
KODKodiak Sciences Inc Common Stock	—	—	B	$39.46
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$49.65
MESOMesoblast Limited American Depositary Shares	D	B	C	$17.19
VCELVericel Corporation	D	B	C	$43.22
ADMAADMA Biologics, Inc.	C	C	C	$9.72
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$6.20
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$37.40
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.56
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.71
INBXInhibrx Biosciences, Inc. Common Stock	D	C	B	$122.72
ALVOAlvotech Ordinary Shares	C	D	B	$5.05
MAZEMaze Therapeutics, Inc. Common Stock	—	—	B	$30.42
NVAXNovavax Inc	B	D	C	$9.44
REPLReplimune Group, Inc.	—	—	A	$15.80
SLBTSL Science Holding Limited Ordinary Shares	—	—	F	$2.64
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	A	$14.92
VORVor Biopharma Inc. Common Stock	—	—	B	$24.01
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$22.95
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.24
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	A	$26.23

About Evaxion A/S American Depositary Share

Evaxion is a clinical-stage TechBio company developing personalized cancer vaccines and vaccines for infectious diseases using its proprietary AI-Immunology platform. The AI-driven platform decodes the immune system to identify novel vaccine candidates for cancer and bacterial/viral diseases with high unmet medical needs. With candidates advancing through clinical development, Evaxion aims to transform patient outcomes through targeted therapeutic innovations.